Home > Quotes > MYGN > Company News
MYGN

Myriad Genetics, Inc. News Headlines

$32.93
*  
0.20
  negative  
0.6%
Get MYGN Alerts
*Delayed - data as of May 17, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MYGN Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Wall Street Set To Extend Nervous Run
5/7/2013 6:32:00 AM - RTT News

Atossa Genetics' Portfolio Can Detect Breast Cancer, But Can These Products Eradicate It?
5/3/2013 3:16:00 PM - Seeking Alpha

Meridian Bioscience Inc. (VIVO) Ex-Dividend Date Scheduled for May 01, 2013
4/30/2013 9:00:04 AM - NASDAQ.com News

Myriad Genetics: Growth Stock, Hot Sector, Solid Industry
4/22/2013 4:55:00 AM - Seeking Alpha

Myriad Downgraded to Neutral - Analyst Blog
4/18/2013 3:10:46 PM - Zacks.com

Tuesday Options Brief: UNH, MYGN & OMPI
4/2/2013 12:50:00 PM - Seeking Alpha

Myriad's New Alliance for HRD Test - Analyst Blog
3/28/2013 2:27:42 PM - Zacks.com

Myriad Genetics Partners With PharmaMar For New HRD Test - Quick Facts
3/26/2013 4:41:00 PM - RTT News

Myriad Retained at Outperform - Analyst Blog
3/8/2013 10:50:01 AM - Zacks.com

Positive Data on Myriad's Prolaris - Analyst Blog
3/6/2013 3:55:01 PM - Zacks.com

Still Neutral on Edwards - Analyst Blog
3/5/2013 6:20:01 PM - Zacks.com

Merge Extends Hyland Partnership - Analyst Blog
3/5/2013 3:40:01 PM - Zacks.com

Reimbursement Update for Myriad - Analyst Blog
3/4/2013 3:40:01 PM - Zacks.com

Noridian Prices Molecular Pathology Codes
3/1/2013 9:58:00 PM - RTT News

Collaborative Research for Cepheid - Analyst Blog
2/21/2013 3:20:01 PM - Zacks.com

Qiagen in Collaboration with Lilly - Analyst Blog
2/15/2013 3:20:01 PM - Zacks.com

Myriad Tops Estimates; Tweaks View - Analyst Blog
2/8/2013 3:30:01 PM - Zacks.com

Myriad Genetics, Inc. Enters Oversold Territory - Tale of the Tape
2/8/2013 11:48:01 AM - Zacks.com

Impressive 4Q for Qiagen - Analyst Blog
1/30/2013 9:50:01 AM - Zacks.com

Qiagen Seeks FDA Approval - Analyst Blog
1/18/2013 6:00:01 PM - Zacks.com

Qiagen Beats 2012 Placement Target - Analyst Blog
1/15/2013 9:50:01 AM - Zacks.com

Intuitive Surgical: A Strong Buy - Analyst Blog
1/2/2013 12:30:01 PM - Zacks.com

Myriad Alleviates to Outperform - Analyst Blog
12/21/2012 5:10:01 PM - Zacks.com

Aggressive Growth: Myriad Genetics
12/19/2012 10:32:00 AM - Seeking Alpha

Myriad Genetics - Aggressive Growth
12/19/2012 1:00:01 AM - Zacks.com